ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Regulus Therapeutics Inc

Regulus Therapeutics Inc (RGLS)

7.88
-0.33
(-4.02%)
8.01
0.13
( 1.65% )

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 43.65M37.75M30.75M114.14M104.12M93.76M84.18M74.83M
Total Current Assets 41.36M35.08M28.18M101.45M100.34M91.69M82.35M71.69M
Cash and Equivalents 37.26M25.83M23.77M29.59M17.12M26.37M38.53M49.46M
Total Non-Current Assets 2.28M2.67M3.63M11.36M3.78M2.08M2.77M3.13M
Total Liabilities 9.65M9.49M9.56M6.55M5.94M6.96M7.77M5.8M
Total Current Liabilities 8.23M8.25M8.51M5.68M5.26M6.48M7.5M4.4M
Total Non-Current Liabilities 1.42M1.24M1.06M868k675k476k274k1.4M
Common Equity 24k25k25k70k70k71k71k71k
Retained Earnings -497.33M-505.15M-513.21M-521.68M-532.72M-546.78M-559.57M-569.21M
Year End December 30 2024 20172018201920202021202220232024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 77.81M27.93M42.08M37.6M68.45M46.72M30.75M84.18M
Total Current Assets 66.74M19.3M40.41M36.73M65.24M44.08M28.18M82.35M
Cash and Equivalents 13.52M13.94M34.12M31.09M60.38M24.23M23.77M38.53M
Total Non-Current Assets 35.22M-5.85M20.02M26.03M54.96M33.29M21.19M76.41M
Total Liabilities 42.59M33.78M22.07M11.58M13.5M13.43M9.56M7.77M
Total Current Liabilities 32.6M26.65M21.6M11.58M5.23M11.66M8.51M7.5M
Total Non-Current Liabilities 9.99M7.14M468k012.94M1.77M1.06M274k
Total Equity 35.22M-5.85M20.02M26.03M54.96M33.29M21.19M76.41M
Common Equity 104k9k25k69k151k22k25k71k
Retained Earnings -345.86M-392.72M-411.32M-427.05M-454.85M-483.18M-513.21M-559.57M

Your Recent History

Delayed Upgrade Clock